Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • H1 Launches ‘Strategy as a Service’ Offering That Helps Life Sciences Companies Cut Time-to-Market in Half

    Sep 20, 2018, 13:50 PM by Michael Croft
    NEW YORK CITY, NY, US - Sep 20, 2018 -  FOR IMMEDIATE RELEASE Media contact:Michelle Faulkner
    +1 617-510-6998
    michelle@big-swing
    Full story
  • Oxford Genetics extends its CRISPR Gene Editing Technology License Agreement from ERS Genomics to support its growth internationally

    Sep 20, 2018, 08:34 AM by Michael Croft
    NEWCASTLE UPON TYNE, UNITED KINGDOM - Sep 20, 2018 - Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, and ERS Genomics have extended their pre-existing non-exclusive, license agreement for the use of CRISPR gene editing technology
    Full story
  • Domainex appoints Dr Trevor Perrior as Chief Executive Officer

    Sep 20, 2018, 06:07 AM by Michael Croft
    CAMBRIDGE, UK - Sep 20, 2018 - Domainex Ltd, a privately-owned drug research services company, is pleased to announce the appointment of Dr Trevor Perrior as Chief Executive Officer, effective from 1st October 2018
    Full story
  • Novel deep learning drug discovery platform gets £1 million innovation boost

    Sep 19, 2018, 04:39 AM by Michael Croft
    , UK - Sep 19, 2018 - Funding to support Artificial Intelligence (AI) in drug discovery takes a significant step forward today as Optibrium™, Intellegens, and Medicines Discovery Catapult secure a grant from Innovate UK to fund a £1 million project
    Full story
  • Rho Recruiting New Team Members at SOCRA Annual Conference

    Sep 18, 2018, 14:52 PM by Michael Croft
    CHAPEL HILL, NC, UNITED STATES - Sep 18, 2018 - WHAT:                 Rho, a full-service contract research organization (CRO), is hiring for a variety of clinical research positions, including clinical research associates (CRAs) and project managers, and will be looking to meet potential applicants during the upcoming Society of Clinical Research Associates (SOCRA) Annual Conference in New Orleans, Louisiana, September 28-30, 2018
    Full story
  • Celebrating 10 Years of Sekisui XenoTech

    Sep 18, 2018, 10:39 AM by Michael Croft
    KANSAS CITY, KS, UNITED STATES - Sep 18, 2018 - 10 years ago Sekisui Chemical Company acquired XenoTech and the future of the groundbreaking, innovative CRO was assured
    Full story
  • Seqster’s Perfect Timing, Powerful Platform Might Change Health

    Sep 18, 2018, 10:25 AM by Michael Croft

    Bio-IT World | Early adopters of Google Health or Microsoft Health Vault may remember the process of consolidating personal health records with a good deal of frustration or just a sense of futility. But Seqster, a privately-held health data management platform that emerged from stealth mode this past February, believes they have gotten it right this time.

    Full story
  • Creative Biolabs Illustrated Its Newly-developed Antibody Affinity Maturation Service

    Sep 18, 2018, 01:38 AM by Michael Croft
    SHIRLEY, NY - Sep 18, 2018 - Sep 18th, 2018, Creative Biolabs, as one of the most experienced supplier in various antibody production and engineering fields, has recently released its newly-developed affinity maturation antibody, which is an indispensable process to improve antibody affinity for an antigen
    Full story
  • LifeArc® announces new CEO appointment

    Sep 17, 2018, 08:16 AM by Michael Croft
    LONDON - Sep 17, 2018 - London, UK, September 4th, 2018. LifeArc, one of the UK's leading medical research charities, is delighted to announce the appointment of Melanie Lee, PhD, CBE as its new Chief Executive Officer (CEO), effective 1st November 2018
    Full story
  • Identification of synthetic, macrocyclic, orally bioavailable cyclophilin inhibitors with potent HCV activity, published in The Journal of Medicinal Chemistry

    Sep 17, 2018, 05:09 AM by Michael Croft
    CAMBRIDGE AND ONGAR, UK - Sep 17, 2018 - A paper entitled ‘Discovery of a Potent and Orally Bioavailable Cyclophilin Inhibitor Derived from the Sanglifehrin Macrocycle’ by authors from Selcia, Cypralis and Gilead has been selected as a featured article by the editors of The Journal of Medicinal Chemistry
    Full story
  • Creative Diagnostics Launches Recombinant HPV L1 VLP for Science Research

    Sep 17, 2018, 04:54 AM by Michael Croft
    SHIRLEY, NY, UNITED STATES - Sep 17, 2018 - As a leader in the manufacture of raw materials, reagents and antibodies for biotechnology industry, Creative Diagnostics now establishes a global-leading virus-like particles (VLPs) manufacture platform using Ex
    Full story
  • Large-Scale Global Genome Projects Choose PacBio Sequencing To Help Decode Life

    Sep 14, 2018, 08:20 AM by Michael Croft

    Bio-IT World News Brief | The Vertebrate Genomes Project recently released the first 15 of an anticipated 66,000 high-quality reference genomes that will eventually include all vertebrate species on Earth.

    Full story
  • Particle Sciences appoints new president

    Sep 13, 2018, 11:59 AM by Michael Croft
    MANCHESTER, UNITED KINGDOM - Sep 13, 2018 - BETHLEHEM, PA, September 13th, 2018 - Particle Sciences, a Lubrizol LifeSciences company and leading pharmaceutical contract development and manufacturing organization (CDMO), announces the appointment of Dr
    Full story
  • Recipharm connects to European Hub for serialisation compliance

    Sep 13, 2018, 11:09 AM by Michael Croft
    STOCKHOLM, SWEDEN - Sep 13, 2018 - Recipharm, a leading contract development and manufacturing organisation (CDMO) has successfully received European Medicines Verification Organisation (EMVO) approval to submit serialisation data to the European Hub
    Full story
  • Certara Acquires Pirana™, a Leading Pharmacometrics Modeling Workbench

    Sep 13, 2018, 09:03 AM by Michael Croft
    PRINCETON, NJ, US - Sep 13, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence solutions, announced today that it has acquired Pirana, a widely used product for connecting and organizing pharmacometric modeling results as well as providing interfaces to a range of software tools used in pharmacometrics modeling
    Full story
  • Google Unveils Dataset Search For Scientists, Other Data Junkies

    Sep 12, 2018, 10:09 AM by Michael Croft
    TOP500 | Google has added a Dataset Search app to its empire of web-based tools, making it easier for researchers, analysts, and anyone else with an affection for data to access publicly available repositories.
    Full story
  • Sekisui XenoTech Adds Rodent, Monkey Hepatocytes to Patented CryostaX® Product Line

    Sep 12, 2018, 09:50 AM by Michael Croft
    KANSAS CITY, KS, UNITED STATES - Sep 12, 2018 - Sekisui XenoTech is expanding its catalog of CryostaX® in vitro drug discovery and preclinical drug development test systems to include pooled Sprague-Dawley rat hepatocytes, which became available in July, CD-1 mouse hepatocytes, which were released this week, and Cynomolgus monkey hepatocytes, which are expected in October
    Full story
  • MR Solutions’ Founder shortlisted for the 2018 NatWest Great British Entrepreneur Awards

    Sep 12, 2018, 05:35 AM by Michael Croft
    GUILDFORD, UNITED KINGDOM - Sep 12, 2018 - Founder and Chairman, Dr David Taylor, of Guildford based MR Solutions has been shortlisted as an Innovation Entrepreneur of the Year for London and the South East in the 2018 NatWest Great British Entrepreneur Awards
    Full story
  • Rho Ranks First for Extra-Large Company by Triangle Business Journal Best Places to Work

    Sep 11, 2018, 14:10 PM by Michael Croft
    CHAPEL HILL, NC - Sep 11, 2018 - For Immediate releaseRho Ranks First for Extra-Large Company byTriangle Business Journal Best Places to WorkCRO recognized for its company culture and flexible work environmentChapel Hill, NC - September 11, 2018  - Rho, a full-service contract research organization (CRO) focused on bringing new products to market through a full range of product development services, announced today that the Triangle Business Journal has ranked the company as the number one extra-large company
    Full story
  • Biodesy Announces New CEO and $20 Million Series C Financing to Accelerate Expansion into Biotherapeutics Discovery and Development Market

    Sep 11, 2018, 10:00 AM by Michael Croft
    SOUTH SAN FRANCISCO, CA, USA - Sep 10, 2018 -  Biodesy Inc., a next-generation biomolecule characterization company, today announced the promotion of Ariel G
    Full story
  • «
  • 261
  • 262 (current)
  • 263
  • 264
  • 265
  • 266
  • 267
  • 268
  • 269
  • 270
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy